# ANK2 Ankyrin-B Syndrome Research Synthesis
## Compared sources
- Falcon: `ANK2_Ankyrin_B_Syndrome-deep-research-falcon.md`; model `Edison Scientific Literature`; generated `2026-04-04T12:57:27.458587`; reported citation count `44`.
- OpenScientist: `ANK2_Ankyrin_B_Syndrome-deep-research-openscientist.md`; model `openscientist-autonomous`; generated `2026-05-04T23:40:13.560114`; reported citation count `33`.
- Citation-file overlap: 0 shared refs, 16 Falcon-only refs, 33 OpenScientist-only refs.
- YAML integration after backfill: 13 references linked to Falcon outputs, 30 references linked to OpenScientist outputs, 3 references linked to both.

## Convergent findings
Both reports were reconciled against the structured YAML entry, whose current pathophysiology focus includes: Disrupted Ion Channel and Transporter Localization in Cardiomyocytes; Cardiac Arrhythmia Susceptibility; Impaired Axonal Development and AIS Structure; Neuronal Network Hyperactivity; Neurodevelopmental Phenotypes.
The structured phenotype surface used for curation includes: Bradycardia; Ventricular Fibrillation; Ventricular Tachycardia; Prolonged QT Interval; Cardiac Arrhythmia; Syncope; Sudden Cardiac Death; Epilepsy.
Shared mechanistic vocabulary detected in both reports includes: ank2, ankyrin-b, cardiac, syndrome, variant, variants, arrhythmia, arrhythmias, genetic, ventricular, family, atrial.
No exact PMID/DOI overlap was detected in the citation files; integration therefore preserves provider-specific literature trails through `references[].found_in`.

## Falcon emphasis
Falcon used the pathophysiology-focused prompt and is most useful for mechanism-first curation: pathophysiology nodes, causal chains, molecular players, cell/process annotations, and concise mechanistic evidence. Parsed report sections included: Comprehensive Research Report: ANK2 Ankyrin-B Syndrome (LQT4), Executive summary, 1. Disease information, 1.1 Definition and overview, 1.2 Key identifiers, 1.3 Synonyms / alternative names, 1.4 Evidence source types, The core disease concept is derived from.
- * **Human family studies** with segregation and clinical phenotyping (e.g., Mohler 2003; Scouarnec 2008) (mohler2003ankyrinbmutationcauses pages 1-2, scouarnec2008dysfunctioninankyrinbdependent pages 1-2)
- * **Human cohort "reappraisal"** in referred patients assessing penetrance and variant validity (Giudicessi & Ackerman 2020) (giudicessi2020establishedlossoffunctionvariants pages 1-5)
- * **Animal and cellular models** (AnkB+/- mice, conditional Ank2 knockouts, knock-in mice) used to establish mechanistic links and test targeted interventions (mohler2003ankyrinbmutationcauses pages 1-2, zhu2018ankyrinbq1283hvariant pages 1-2, roberts2019ankyrinbdysfunctionpredisposes pages 9-10)
- * Pathogenic/likely pathogenic ANK2 variants in key functional regions (e.g., E1425G/E1458G, S646F, Q1283H) are associated with increased arrhythmia susceptibility. (mohler2003ankyrinbmutationcauses pages 1-2, swayne2017novelvariantin pages 1-2, zhu2018ankyrinbq1283hvariant pages 1-2)
- No validated protective genetic or environmental factors specific to ankyrin-B syndrome were identified in retrieved evidence.
Falcon-only citations retained for curation include: DOI:10.1016/j.hrthm.2015.11.013, DOI:10.1016/j.hrthm.2017.07.032, DOI:10.1038/nature01335, DOI:10.1073/pnas.0402546101, DOI:10.1073/pnas.0805500105, DOI:10.1152/ajpheart.00503.2010, DOI:10.1161/circgen.119.002851, DOI:10.1161/circgenetics.116.001537, DOI:10.1161/circresaha.110.224592, DOI:10.1161/circulationaha.111.023986, DOI:10.1161/circulationaha.118.034541, DOI:10.1172/jci125538, ...

## OpenScientist emphasis
OpenScientist used the broader disease-characteristics prompt and is most useful as a breadth check across etiology, diagnostics, prognosis, treatment, model systems, and evidence gaps while still covering mechanisms. Parsed report sections included: Comprehensive Disease Report: ANK2 Ankyrin-B Syndrome, Summary, 1. Disease Information, Overview, Key Identifiers, Synonyms and Alternative Names, Ankyrin-B syndrome, Cardiac arrhythmia, ankyrin-B-related.
- This report synthesizes evidence from 43 peer-reviewed publications to provide a comprehensive characterization of ANK2 Ankyrin-B Syndrome across all disease dimensions, from molecular pathophysiology to clinical management, suitable for populating a disease knowledge base entry.
- The information in this report is derived from aggregated disease-level resources including OMIM, ClinVar, ClinGen, and primary literature (43 peer-reviewed publications), supplemented by evidence from animal model studies and computational modeling.
- The primary cause of ANK2 Ankyrin-B Syndrome is **genetic**: loss-of-function variants in the *ANK2* gene encoding ankyrin-B. The disease follows autosomal dominant inheritance with incomplete penetrance and variable expressivity.
- A novel mechanism was also described involving a **reciprocal chromosomal translocation** between chromosomes 4q25 and 9q26 that transects the *ANK2* gene, resulting in ankyrin-B haploinsufficiency and clinical features of ankyrin-B syndrome ([PMID: 27916589](https://pubmed.ncbi.nlm.nih.gov/27916589/)).
- **Causal variants**: Multiple loss-of-function variants in *ANK2* have been identified, including E1425G, V1516D, T1404I, R1788W, L1622I, Q1283H, and W1535R
OpenScientist-only citations retained for curation include: PMID:10579720, PMID:11781319, PMID:12571597, PMID:14722080, PMID:15178757, PMID:15262991, PMID:16253912, PMID:17242276, PMID:17416611, PMID:17940615, PMID:18782775, PMID:18832177, ...

## Contrast and curation implications
- Falcon and OpenScientist are complementary rather than interchangeable: Falcon is narrower and mechanism-oriented, while OpenScientist is broader and more clinical/contextual.
- Non-overlapping citations were kept because they point to different curator review paths: mechanistic substantiation from Falcon and broader clinical or translational substantiation from OpenScientist.
- The YAML integration preserves both trails through `references[].found_in`; references with cache-resolvable abstracts also received structured findings/evidence snippets during backfill.
- Provider disagreements or non-overlapping citations should be treated as prioritization cues for curator review rather than as direct contradictions unless the cited papers conflict on the same claim.

## Follow-up checks
- Review provider-specific citations with no shared PMID/DOI overlap for possible high-value additions to specific pathophysiology, phenotype, diagnostic, or treatment sections.
- Keep exact evidence snippets tied to fetched reference-cache text; do not promote report prose directly into YAML evidence without validating the cited abstract or source.
